Skip to main navigation
Skip to search
Skip to main content
Erasmus University Rotterdam Home
Help & FAQ
Link opens in a new tab
Search content at Erasmus University Rotterdam
Home
Research output
Researchers
Research units
Activities
Prizes
Press/Media
Datasets
Moleculaire afwijkingen en doelgerichte therapieën in blaaskanker
Translated title of the contribution
:
Molecular alterations and personalized therapies in bladder cancer
Mitchell Olislagers
,
Tahlita C.M. Zuiverloon
*
*
Corresponding author for this work
Urology
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
9
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Molecular alterations and personalized therapies in bladder cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Personalized Medicine
100%
Bladder Cancer
100%
Biological Marker
75%
Decision Making
25%
Treatment Response
25%
Carcinogenesis
25%
Patient Selection
25%
Cell Surface
25%
Immune Checkpoint Inhibitor
25%
Targeted Therapy
25%
Antibody-Drug Conjugate
25%
Cell Adhesion
25%
Fibroblast Growth Factor
25%
Trophoblast
25%
Immunology and Microbiology
Nectin
100%
Cell Adhesion
50%
Cell Surface
50%
Decision Making
50%
Antibody Drug Conjugate
50%
Trophoblast
50%
Fibroblast Growth Factor
50%
Immune Checkpoint Inhibitor
50%
Biochemistry, Genetics and Molecular Biology
Cell Adhesion
50%
Trophoblast
50%
Decision Making
50%
Conjugate
50%
Carcinogenesis
50%
Fibroblast Growth Factor
50%
Targeted Therapy
50%
Immune Checkpoint Inhibitor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Nectin
50%